These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7236023)

  • 1. Extravasation of vessicant antineoplastics: clinical and experimental findings.
    Dorr RT
    Ariz Med; 1981 Apr; 38(4):271-5. PubMed ID: 7236023
    [No Abstract]   [Full Text] [Related]  

  • 2. Implementing guidelines for managing extravasation of antineoplastics.
    Hirsh JD; Conlon PF
    Am J Hosp Pharm; 1983 Sep; 40(9):1516-9. PubMed ID: 6624754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexrazoxane for anthracycline extravasation.
    Langer SW
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1081-8. PubMed ID: 18028016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The skin and alopecia].
    Ishihara K
    Nihon Rinsho; 2003 Jun; 61(6):1001-5. PubMed ID: 12806950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The extravasation of cytostatic drugs: its diagnosis, evolution and treatment].
    Llop JC; Mateu J; Llorente A
    Med Clin (Barc); 1993 Jun; 101(3):105-9. PubMed ID: 8315981
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous reactions to chemotherapy: commonly seen, less described, little understood.
    Sanborn RE; Sauer DA
    Dermatol Clin; 2008 Jan; 26(1):103-19, ix. PubMed ID: 18023774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Oncology Nursing Society extravasation guidelines.
    Wengström Y; Margulies A;
    Eur J Oncol Nurs; 2008 Sep; 12(4):357-61. PubMed ID: 18765210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for the safe handling of injectable antineoplastic drug products.
    Zimmerman PF; Larsen RK; Barkley EW; Gallelli JF
    Am J Hosp Pharm; 1981 Nov; 38(11):1693-5. PubMed ID: 7304621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [41 local complications of chemotherapy].
    Abbes M; Picard JL; Bourgeon Y; Namer M; Wolkiewicz J; Lesbats G
    Ann Chir Plast Esthet; 1986; 31(2):149-56. PubMed ID: 2429602
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of chemotherapy on skin and hair.
    Ailor SK; Miles S
    Mo Med; 2007; 104(2):124-6. PubMed ID: 17536440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk.
    Sauerland C; Engelking C; Wickham R; Corbi D
    Oncol Nurs Forum; 2006 Nov; 33(6):1134-41. PubMed ID: 17149396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatologic toxicity of chemotherapeutic agents.
    Payne AS; James WD; Weiss RB
    Semin Oncol; 2006 Feb; 33(1):86-97. PubMed ID: 16473647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoprotection against doxorubicin toxicity.
    Perkins TE; Malkinson FD; Finnerud CW
    Arch Dermatol; 2001 Nov; 137(11):1528-9. PubMed ID: 11708966
    [No Abstract]   [Full Text] [Related]  

  • 14. [The significance of extravasation in oncological care].
    Zatkóné Puskás G
    Magy Onkol; 2008 Mar; 52(1):75-80. PubMed ID: 18403301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of i.v. chemotherapy & biotherapy agents.
    Ohio Nurses Association
    Ohio Nurses Rev; 2008; 83(1):6-7. PubMed ID: 18410049
    [No Abstract]   [Full Text] [Related]  

  • 16. Mucocutaneous reactions to chemotherapy.
    Valks R; García-Díez A; Fernández-Herrera J
    J Am Acad Dermatol; 2000 Apr; 42(4):699. PubMed ID: 10727329
    [No Abstract]   [Full Text] [Related]  

  • 17. [Local complications of long term treatment with intravenous cytostatic agents--prevention and treatment].
    Koralewski P
    Wiad Lek; 1990 Mar 1-15; 43(5-6):208-11. PubMed ID: 2195775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imatinib mesylate induced skin hypopigmentation.
    Talwar V; Doval DC; Bhatia K
    J Assoc Physicians India; 2007 Jul; 55():527. PubMed ID: 17907508
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neurotoxicity and dermatologic toxicity of cancer chemotherapy].
    Nakane M
    Gan To Kagaku Ryoho; 2006 Jan; 33(1):29-33. PubMed ID: 16410694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular hyperplasia on the face subsequent to therapy with sorafenib. A new skin side effect.
    Lopez V; Pinazo I; Marti N; Monteagudo C; Jorda E
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):959-60. PubMed ID: 18785888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.